Compare VIDA & ELOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VIDA | ELOX |
|---|---|---|
| Founded | 2022 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 64.7M | 60.3M |
| IPO Year | 2026 | 2013 |
| Metric | VIDA | ELOX |
|---|---|---|
| Price | $1.60 | $15.31 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $38.25 |
| AVG Volume (30 Days) | ★ 110.6K | 21.4K |
| Earning Date | 11-19-2026 | 08-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 41.67 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.58 | $10.00 |
| 52 Week High | $4.25 | $23.40 |
| Indicator | VIDA | ELOX |
|---|---|---|
| Relative Strength Index (RSI) | 32.83 | 44.16 |
| Support Level | N/A | $13.92 |
| Resistance Level | $2.79 | $19.43 |
| Average True Range (ATR) | 0.15 | 1.39 |
| MACD | -0.01 | -0.19 |
| Stochastic Oscillator | 10.00 | 23.89 |
Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (NMs) to enable the production of full-length proteins. The exaluren, the company's investigational drug product for the treatment of rare kidney diseases, and, through the collaboration with Almirall, S.A. (Almirall), ZKN-013 for the treatment of rare skin diseases.